The Healthy @Reader's Digest on MSN

Here's how I knew I had tonsil stones: How an oddly common annoyance upended a patient's quality of life

Not only are tonsil stones a "thing," they're far more prevalent than they're discussed. One woman details her year-long ...
KUNC

15 killed in mass shooting in Sydney. And, Rob Reiner and his wife found dead

Here's what we know about the mass shooting that left at least 15 people dead. And, authorities found director Rob Reiner and ...
Marketplace

Rising insurance rates drive people to cash-only care

Costly health insurance is fueling patient interest in a cash-only model called direct primary care.
Enterprise News on MSN

Point32Health volunteers support local nonprofits on Giving Tuesday

Volunteers from Point32Health supported local nonprofits on Giving Tuesday. Sixteen colleagues participated in a food ...
The American Journal of Managed Care

FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer

The FDA approved fam-trastuzumab derextecan-nki (Enhertu; Daiichi Sankyo, Inc), a HER2-directed antibody-drug conjugate (ADC), in combination with pertuzumab as a first-line treatment for patients ...
MPR

Enhertu Plus Pertuzumab Approved for First-Line HER2+ Breast Cancer

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).
PharmExec

FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer

Enhertu plus Perjeta is the first new first-line treatment for HER2-positive breast cancer in over a decade, approved by the ...
iBerkshires.com

BHS' New North County Urgent Care Center Opens Tuesday

There is a waiting area and reception desk to the right of the Williamstown Medical entrance. WILLIAMSTOWN, Mass. — Staff and ...